Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) generates a steady flow of news related to digital investigations, AI-powered analytics and public safety technology. As a global provider of digital investigative and intelligence solutions for public safety organizations, intelligence agencies, defense organizations and enterprises, the company frequently issues updates on its software platform, strategic initiatives and regulatory milestones.
News about Cellebrite often covers product and platform innovation, including releases that expand its Digital Investigation Platform. Recent announcements have highlighted enhancements to its flagship digital forensics solution, Inseyets, the expanded and reimagined Guardian suite for investigations and analytics, and the introduction of Guardian Investigate, a SaaS-based investigative solution that uses agentic AI to analyze multiple evidence types. Updates also describe new deployment options such as AWS GovCloud for Pathfinder and developments in the Cellebrite Government Cloud.
Investors and practitioners following CLBT news will also see corporate and strategic developments, such as the agreement and subsequent completion of the Corellium acquisition, which adds Arm-based mobile virtualization capabilities for security research and testing. Other coverage includes leadership changes, like the appointment of a new chief executive officer and chief financial officer, and governance events such as shareholder meeting outcomes.
Cellebrite’s news flow additionally features public sector and compliance milestones, including progress toward FedRAMP High authorization for its government cloud environment with sponsorship from the U.S. Department of Justice, and partnerships that support investigations into crimes against children. For ongoing insight into how Cellebrite’s technology, customer relationships and regulatory posture evolve, readers can review this CLBT news page regularly for the latest press releases and official updates.
Cellebrite (Nasdaq: CLBT) announced its Spring 2026 Release on March 31, 2026, expanding device access to the widest range of iOS and Android systems, including support for iPhone 17 and iOS 26. The release adds Safeguard Mode, drone forensics, and brings Corellium to Google Cloud (public preview) for Arm-based virtual testing.
Features aim to speed field data capture, broaden forensic sources, and let automakers virtually test vehicle software at scale in Google Cloud Axion C4A metal instances.
Cellebrite (NASDAQ: CLBT) announced Guardian Investigate, now generally available worldwide as of March 18, 2026. The AI-powered investigative management platform combines agentic AI, analytics and centralized case workflows to enable real-time evidence ingestion, collaborative case timelines, task management and maintained chain of custody across departments and agencies.
Guardian Investigate integrates with Guardian evidence management and complements Cellebrite Genesis for standalone rapid deployment.
Cellebrite (NASDAQ: CLBT) on March 16, 2026 launched Genesis, an agentic AI investigative platform now open for early access that aims to shorten investigative tasks from weeks to minutes.
Genesis analyzes phone extractions, CDRs, documents, images and video with claimed forensic-grade precision, integrates with existing Cellebrite tools, and adheres to NIST framework and SOC 2 standards. Cellebrite says nearly 3 million investigations annually and a customer base of over 7,000 support Genesis adoption; demonstrations planned at the C2C user conference.
Cellebrite (Nasdaq: CLBT) filed its Annual Report on Form 20-F for the year ended December 31, 2025 on March 4, 2026. The filing is available on the company's investor relations website and the U.S. SEC website. Shareholders can request a free hard copy by emailing investors@cellebrite.com.
References to external websites or social media do not constitute incorporation by reference into this release.
Cellebrite (NASDAQ: CLBT) completed its acquisition of SCG Canada, Inc. on March 2, 2026, adding hand-held UAV/drone forensic capabilities that access data from more than 80 common UAVs.
The integration extends Cellebrite's AI-powered platform to drone flight logs, video and other mission-critical artifacts; financial terms were not disclosed.
Cellebrite (NASDAQ: CLBT) will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026. The company will appear in a 10:45 a.m. ET fireside chat featuring CFO David Barter and VP of Investor Relations Andrew Kramer. Details and a webcast link are available.
Cellebrite (NASDAQ: CLBT) reported record fourth-quarter and full-year 2025 results with Q4 revenue $128.8M (+18% YoY), total ARR $480.8M (+21% YoY) and FY revenue $475.7M (+19% YoY). Non-GAAP net income was $130.5M for FY2025 and adjusted EBITDA was $38.3M in Q4 (29.8% margin) and $127.6M for the year (26.8% margin). The company completed the acquisition of Corellium on Dec 1, 2025 (adding $16.1M ARR) and announced an agreement to acquire SCG Canada for drone forensics. 2026 guidance targets ARR of $567M–$573M and revenue of $565M–$571M.
Cellebrite (NASDAQ: CLBT) released its 2026 Industry Trends Report surveying 1,200 practitioners across 63 countries. Key findings: 97% cite smartphones as the top source of digital evidence (up 24 points from 2024), 95% say digital evidence raises solvability, and 65% expect AI to accelerate investigations.
Cloud receptiveness rose to 42%, though two-thirds still share evidence via physical media, creating custody risks. Guardian platform saw triple-digit YoY growth in customers, users and data stored in 2025.
Cellebrite (NASDAQ: CLBT) announced it will report fourth-quarter and fiscal year 2025 financial results before U.S. markets open on Wednesday, February 11, 2026. A live conference call and webcast to review Q4 2025 results and discuss the company’s 2026 outlook will follow at 8:30 a.m. ET the same day.
Call-in numbers, conference ID CLBTQ425, and live webcast links are provided; historical financial tables and supplemental data will be posted to the company’s quarterly results page on the investor relations website.
Cellebrite (NASDAQ: CLBT) completed the acquisition of Corellium on Dec 2, 2025, combining Corellium’s Arm-based virtualization with Cellebrite’s AI-powered digital investigation platform.
The transaction value was $170 million (including $150 million cash at closing, $20 million converted to equity, and up to $30 million in performance-based cash over two years). Corellium CTO Chris Wade joined Cellebrite as CTO. CFIUS permitted closing under a negotiated national security agreement pending formal agency execution. Cellebrite said one month of Corellium results will not materially affect 2025 outlook.